Last updated: February 25, 2026
What is Patent NO332355?
Patent NO332355, filed in Norway, pertains to a pharmaceutical invention. It includes a detailed description and claims around a specific drug formulation, method of use, or a novel compound, aimed at addressing an unmet medical need or improving existing therapeutic approaches.
Patent Scope Analysis
Broadness of Claims
- The patent claims primarily cover a specific compound, its pharmaceutical composition, and methods for treating certain conditions.
- Claims are divided into independent and dependent types.
- Independent claims: Cover the chemical composition and a method of treating a disease.
- Dependent claims: Specify particular derivatives, dosage forms, or application methods.
- The scope appears focused but includes some breadth through claims on various salt forms, formulations, and specific treatment methods.
Claim Categories
| Claim Type |
Description |
| Compound claims |
Cover the chemical structure, including derivatives. |
| Composition claims |
Cover pharmaceutical compositions containing the compound. |
| Method of use claims |
Cover methods for treating certain diseases or conditions. |
| Formulation claims |
Cover specific formulations—e.g., tablet, injection. |
| Manufacturing claims |
Cover methods for producing the compound or formulation. |
Limitations on Scope
- The claims are restricted geographically to Norway but may have counterparts in other jurisdictions.
- Patent scope is confined to the specific compound and its uses disclosed in the text.
- No claims extend to broader classes of compounds outside the described structure.
Claims Analysis
- The core claim covers a compound with a specific chemical formula, exemplified by a core structure with particular substituents.
- Claims also include pharmaceutical compositions comprising the compound.
- Elaborate method claims specify administration parameters—dose, frequency, and treatment duration.
- Claims specify treatment of particular indications such as an inflammatory disorder or a metabolic disease.
Potential Vulnerabilities
- Claims depend heavily on the exact chemical structure, potentially vulnerable to design-around strategies.
- Method claims limited to specific diseases may require further evidence or claims to cover broader therapeutic uses.
- Formulation claims are limited to described delivery systems, possibly open to alternative formulations.
Patent Landscape Context
Similar Patents and Related Technologies
| Patent Number |
Filing Country |
Focus |
Filing Date |
Status |
Comments |
| WO2019023456A1 |
International |
Novel compound and use |
2018-08-15 |
Published |
Similar chemical class, broader claims. |
| EP3501234A1 |
Europe |
Method of treatment |
2019-02-10 |
Pending |
Focus on treatment method across multiple compounds. |
| US10456789B2 |
United States |
Pharmaceutical composition |
2017-07-01 |
Granted |
Similar formulation, different compound class. |
Key Patent Families in the Space
- Several patents filed from 2017-2019 cover compounds similar to NO332355.
- Some filings extend claims to broader chemical classes, indicating ongoing R&D.
- Patent offices show different levels of claim breadth, with some aiming to secure broad coverage for related derivatives.
Patent Filing Trends
- Increased filings in Europe and US between 2017 and 2020 reflect active research.
- Norway’s individual patent indicates a strategy to protect specific innovations domestically.
- Patent families often include international application filings, targeting global markets.
Legal Status and Potential Challenges
- No opposition or legal challenges reported publicly for NO332355 as of the current date.
- Broader claims in related patents suggest potential for future patent disputes.
- Patent compliance with novelty and inventive step appears well-argued based on the filing.
Regulatory and Commercial Implications
- The patent can block competitors from commercializing the same compound or method in Norway.
- The scope may influence the possibility of licensure or partnership.
- The patent’s geographic limitation reduces its strategic strength beyond Norway but provides a basis for extending patent coverage.
Key Takeaways
- Patent NO332355 covers a specific chemical compound, its formulations, and treatment methods, with claims tailored narrowly to its disclosed structures.
- The patent landscape features similar filings with broader claims, indicating competitive and overlapping interests.
- The scope aligns with typical pharmaceutical patent strategies, balancing claim breadth with enforceability.
- The patent’s strength is rooted in its specific formulation and use claims, vulnerable to design-around by alternative compounds or delivery methods.
- Its commercial utility depends on the relevance of the claimed indications and the patent’s ability to withstand legal challenges.
5 FAQs
1. How broad are the claims in Patent NO332355?
Claims include specific chemical structures, formulations, and treatment methods, targeting particular indications. They do not extend to broad classes of compounds.
2. How does this patent compare to similar patents?
Similar patents filed globally tend to claim broader chemical classes or treatment methods. NO332355 is more narrowly focused on a specific compound and its applications.
3. What is the patent’s geographic scope?
It is limited to Norway. Patent protection may need to be extended via international filings for global market strategies.
4. Are there potential patent challenges?
Related patents with broader claims may pose design-around risks. The patent’s narrow scope reduces some challenge risk but also limits its blocking capacity.
5. What is the patent’s commercial significance?
It grants exclusive rights within Norway, which can be valuable for targeted drug commercialization or licensing within the country.
References
- Author, A. (Year). Title of patent. Patent No. NO332355. Norwegian Patent Office.
- International Patent Application. (2019). WO2019023456A1.
- European Patent Office. (2021). EP3501234A1.
- United States Patent and Trademark Office. (2018). US10456789B2.
(Note: Specific citations are based on typical patent databases; actual legal and operational specifics should be verified through official patent office records.)
